	C 2012 Dec 31	C 2014 Mar 31	2015 Mar 31	R 2016 Mar 31	2017 Mar 31	2018 Mar 31	2019 Mar 31	2020 Mar 31	2021 Mar 31	2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31

Period length: Source:	12M AR	15M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M PRESS
Total Revenue	1,653	2,276	2,289	2,615	2,903	3,299	3,679	4,093	4,310	4,919	5,349	5,849	6,409	6,929
Cost of Operating Revenue	1,004	1,333	1,336	1,518	1,743	1,935	2,124	2,398	2,469	2,748	3,071	3,320	3,598	3,769
Gross Profit	649	943	953	1,097	1,160	1,363	1,555	1,695	1,841	2,171	2,278	2,529	2,811	3,160
Gross Margin	39.3	41.4	41.6	42.0	40.0	41.3	42.3	41.4	42.7	44.1	42.6	43.2	43.9	45.6
Total Operating Expenses	1,468	2,022	1,987	2,261	2,517	2,785	3,086	3,388	3,443	3,893	4,209	4,464	4,783	5,113
Operating Profit	185	254	302	354	386	514	592	705	867	1,026	1,140	1,384	1,626	1,816
Operating Margin	11.2	11.1	13.2	13.5	13.3	15.6	16.1	17.2	20.1	20.9	21.3	23.7	25.4	26.2
Financing Income/(Expense) - Net	19	27	39	45	51	63	95	97	58	53	124	209	245	-25
Profit before Taxes	215	295	344	398	436	621	699	803	926	1,080	1,274	1,618	1,887	2,079
Income Taxes	70	96	115	143	160	220	249	210	235	281	324	417	473	527
Profit after Tax	145	198	229	255	277	401	450	593	691	799	949	1,201	1,414	1,552
PAT Margin	8.8	8.7	10.0	9.8	9.5	12.2	12.2	14.5	16.0	16.2	17.8	20.5	22.1	22.4
EPS - Basic - ex Extraordinary Items	68.10	93.39	107.75	120.12	130.19	188.81	211.93	279.04	325.04	375.87	446.80	565.30	665.64	730.36
EPS - Diluted - ex Extraordinary Items	68.10	93.39	107.75	120.12	130.19	188.81	211.93	279.04	325.04	375.87	446.80	565.30	665.64	730.36
EBIT	185	254	302	354	386	514	592	705	867	1,026	1,140	1,384	1,626	1,816
EBITDA	204	276	317	368	402	530	609	765	925	1,092	1,210	1,456	1,698	1,892
EBITDA Margin	12.4	12.1	13.8	14.1	13.9	16.1	16.6	18.7	21.5	22.2	22.6	24.9	26.5	27.3

Balance Sheet

Abridged

Understanding Balance Sheet

Abbott India Ltd. balance sheet covering assets, liabilities, equity and borrowings across annual and quarterly periods.

Consolidated

Standalone

Annual

Interim

	R 2012 Dec 31	C 2014 Mar 31	R 2015 Mar 31	R 2016 Mar 31	R 2017 Mar 31	R 2018 Mar 31	2019 Mar 31	2020 Mar 31	C 2021 Mar 31	2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31

Source:	AR	AR	AR	AR	AR	AR	AR	AR	IR	AR	AR	AR	AR	PRESS
Total Current Assets	774	996	1,236	1,451	1,893	2,265	2,761	3,205	3,487	3,853	3,025	3,246	4,765	3,771
Long-Term Investments	-	2	12	13	21	4	4	5	47	16	1,189	1,618	720	2,348
Property Plant & Equipment - Net	104	96	96	108	113	81	104	271	250	263	233	228	348	333
Total Non-Current Assets	133	143	130	166	173	151	180	342	353	371	1,530	1,948	1,152	2,731
Total Assets	907	1,139	1,367	1,617	2,066	2,416	2,941	3,547	3,840	4,224	4,556	5,193	5,917	6,502
Total Current Liabilities	230	306	317	382	632	668	857	891	1,031	1,203	1,206	1,343	1,407	1,477
Long Term Debt	-	-	-	-	-	-	-	139	118	109	67	37	158	134
Total Non-Current Liabilities	31	45	34	39	47	55	75	224	207	201	161	152	277	251
Total Liabilities	260	351	352	421	679	723	932	1,115	1,238	1,404	1,367	1,495	1,684	1,728
Total Shareholders' Equity	647	788	1,015	1,196	1,387	1,693	2,009	2,432	2,602	2,820	3,189	3,699	4,233	4,774
Total Equity	647	788	1,015	1,196	1,387	1,693	2,009	2,432	2,602	2,820	3,189	3,699	4,233	4,774
Total Liabilities & Equity	907	1,139	1,367	1,617	2,066	2,416	2,941	3,547	3,840	4,224	4,556	5,193	5,917	6,502

Cash Flow

Abridged

Understanding Cash Flow Statement

Abbott India Ltd. cash flow statement covering operating, investing and financing activities across annual and quarterly periods.

Consolidated

Standalone

Annual

Interim

	2012 Dec 31	C 2014 Mar 31	2015 Mar 31	C 2016 Mar 31	2017 Mar 31	2018 Mar 31	2019 Mar 31	2020 Mar 31	2021 Mar 31	2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31

Period length: Source:	12M AR	15M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M PRESS
Operating CF bef Changes in Working Cap	165	216	231	276	296	402	455	676	801	887	972	1,227	1,394	1,756
Working Capital - Increase/(Decrease)	-40	-28	23	22	66	-187	134	70	11	129	23	129	-263	-70
Net CF from Operating Activities	125	188	254	298	362	216	590	746	813	1,016	995	1,356	1,130	1,686
Capital Expenditures - Net	17	4	16	23	21	-27	-4	16	23	44	34	48	52	12
Net CF from Investing Activities	-82	-176	-226	-127	-211	-278	-350	-522	-158	-465	-250	-560	57	-756
Dividends Paid - Cash - Total	42	42	57	66	74	85	117	138	531	584	584	691	871	1,009
Debt - LT & ST - Issuance/(Retirement) - Total	-	-	-	-	-	-	-	-50	-50	-52	-54	-54	-47	-39
Net Cash Flow from Financing Activities	-42	-42	-57	-79	-90	-102	-141	-217	-581	-637	-638	-745	-918	-1,048
Free Cash Flow to Equity	108	184	239	275	341	243	594	681	739	920	908	1,254	1,031	1,635
Free Operating CF net dividend	65	127	179	209	266	106	460	592	258	388	377	617	206	635
Free Operating CF	107	170	236	275	341	191	577	730	789	972	961	1,308	1,078	1,645

Business Segment Analysis

FY End:

Mar 25

Abbott India Ltd. business segment breakdown covering revenue, operating income and assets across key divisions for the selected financial year.

Capex

Pharmaceuticals (100.0%)₹ 52.60 Cr

Revenue / Sales

Pharmaceuticals (100.0%)₹ 6,409.15 Cr

Assets

Pharmaceuticals (100.0%)₹ 5,917.31 Cr

Operating Income

Pharmaceuticals (100.0%)₹ 1,626.11 Cr

Regional Segment Analysis

FY End:

Mar 25

Abbott India Ltd. geographic revenue split showing domestic and international market performance across revenue and income for the selected financial year.

Revenue / Sales

India (98.8%)₹ 6,269.89 CrOutside India (1.2%)₹ 75.51 Cr

Historical Segment Analysis

Track how Abbott India Ltd. segment contributions have evolved over multiple financial years to see which divisions are growing, shrinking or gaining strategic importance.

Capex

Sales

Assets

Operating Income

Business

Regional

Business

	2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31

Pharmaceuticals	44	34	48	53

Frequently Asked Questions

What is the revenue of Abbott India Ltd.?

The latest trailing twelve month revenue of Abbott India Ltd. is ₹ 6,929.05 Cr, reflecting a 1-year growth of 8.11% and a 3-year CAGR of 9.01%. Annual and quarterly revenue trends are available in the Income Statement section.

What is the net profit of Abbott India Ltd.?

The latest trailing twelve month net profit (PAT) of Abbott India Ltd. is ₹ 1,552.02 Cr, with a 3-year earnings CAGR of 17.80%. Detailed profit history across annual and quarterly periods is in the Income Statement section.

What is the EBITDA of Abbott India Ltd.?

The trailing twelve month EBITDA of Abbott India Ltd. is approximately ₹ 1,816.12 Cr (based on an operating margin of 26.21%). EBITDA reflects core operating profitability before interest, taxes, depreciation and amortisation.

What is the EPS of Abbott India Ltd.?

The trailing twelve month Earnings Per Share (EPS) of Abbott India Ltd. is 730.36. EPS trends across annual and quarterly periods are visible in the Income Statement section.

What is the debt level of Abbott India Ltd.?

The debt-to-equity ratio of Abbott India Ltd. stands at 0.04. The interest coverage ratio is 72.67x, reflecting the company's ability to service debt from operating earnings. The full breakdown of total borrowings is in the Balance Sheet section.

What is the book value per share of Abbott India Ltd.?

The estimated book value per share of Abbott India Ltd. is 2,246.79 (derived from a P/B ratio of 11.68 and market price of ₹ 26,245.00), reflecting the net asset value attributable to each share. See the Balance Sheet section for a full breakdown.

What is the cash flow from operations of Abbott India Ltd.?

The trailing twelve month operating cash flow of Abbott India Ltd. is ₹ 1,685.63 Cr. Annual and quarterly cash flow data is available in the Cash Flow section of the Statements tab.

Does Abbott India Ltd. report consolidated or standalone financials?

Abbott India Ltd. reports consolidated financials. You can toggle between consolidated and standalone views using the switch at the top of each statement section.